168 related articles for article (PubMed ID: 12147456)
41. Maternal Antibodies to Herpes Virus Antigens and Risk of Gastroschisis in Offspring.
Werler MM; Parker SE; Hedman K; Gissler M; Ritvanen A; Surcel HM
Am J Epidemiol; 2016 Dec; 184(12):902-912. PubMed ID: 27856447
[TBL] [Abstract][Full Text] [Related]
42. Epstein-Barr virus-associated smooth muscle tumours after transplantation, infection with human immunodeficiency virus and congenital immunodeficiency syndromes.
Hussein K; Maecker-Kolhoff B; Donnerstag F; Laenger F; Kreipe H; Jonigk D
Pathobiology; 2013; 80(6):297-301. PubMed ID: 24013109
[TBL] [Abstract][Full Text] [Related]
43. [Specific risks of liver transplantation in patients co-infected with hepatitis C virus and human immunodeficiency virus].
Dumortier J; Chiarello P; Adham M; Delafosse B; Chayvialle JA; Scoazec JY; Boillot O
Gastroenterol Clin Biol; 2002 Nov; 26(11):1061-2. PubMed ID: 12483148
[No Abstract] [Full Text] [Related]
44. Therapy of cytomegalovirus infections with ganciclovir: a critical appraisal.
Collier AC; Corey L
Curr Clin Top Infect Dis; 1992; 12():309-28. PubMed ID: 1322676
[No Abstract] [Full Text] [Related]
45. [Immunodeficiency and its complications of bone marrow transplantation from unrelated donors].
Sao H
Rinsho Ketsueki; 2000 Jun; 41(6):477-81. PubMed ID: 10921345
[No Abstract] [Full Text] [Related]
46. Viral infection in the renal transplant patient.
Rubin RH; Tolkoff-Rubin NE
Proc Eur Dial Transplant Assoc; 1983; 19():513-26. PubMed ID: 6308602
[TBL] [Abstract][Full Text] [Related]
47. Long-term follow-up of de novo monoclonal gammopathies.
Modesto A; Rostaing L; Abbal M; Niquet L; Tkaczuk J; Durand D; Ohayon E
Transplant Proc; 1994 Feb; 26(1):282. PubMed ID: 8108981
[No Abstract] [Full Text] [Related]
48. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
49. Epstein-Barr virus-associated smooth muscle tumors in children following solid organ transplantation: a review.
Jossen J; Chu J; Hotchkiss H; Wistinghausen B; Iyer K; Magid M; Kamath A; Roayaie S; Arnon R
Pediatr Transplant; 2015 Mar; 19(2):235-43. PubMed ID: 25572657
[TBL] [Abstract][Full Text] [Related]
50. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
[TBL] [Abstract][Full Text] [Related]
51. [Epstein-Barr virus and cytomegalovirus primary infections: a comparative study in 52 immunocompetent adults].
Batalla AS; Benito D; Baumard S; Brodard V; Servettaz A; Jaussaud R; Strady C
Med Mal Infect; 2011 Jan; 41(1):14-9. PubMed ID: 20832213
[TBL] [Abstract][Full Text] [Related]
52. Lymphoproliferative response to herpes simplex virus type 1, cytomegalovirus, Epstein-Barr virus, varicella zoster virus, human herpes virus 6, 7, and 8 antigen stimulation in pediatric allogeneic stem cell transplant recipients.
Cheng FW; Chan PK; Lee V; Leung WK; Shing MK; Li CK; Leung TF
Pediatr Transplant; 2010 Sep; 14(6):761-9. PubMed ID: 20534025
[TBL] [Abstract][Full Text] [Related]
53. Prospective monitoring of cytomegalovirus, Epstein-Barr virus, BK virus, and JC virus infections on belatacept therapy after a kidney transplant.
Bassil N; Rostaing L; Mengelle C; Kallab S; Esposito L; Guitard J; Cardeau-Desangles I; Weclawiak H; Izopet J; Kamar N
Exp Clin Transplant; 2014 Jun; 12(3):212-9. PubMed ID: 24907721
[TBL] [Abstract][Full Text] [Related]
54. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.
Purtilo DT; Tatsumi E; Manolov G; Manolova Y; Harada S; Lipscomb H; Krueger G
Int Rev Exp Pathol; 1985; 27():113-83. PubMed ID: 3017882
[No Abstract] [Full Text] [Related]
55. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S;
Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
[TBL] [Abstract][Full Text] [Related]
56. Risk Factors for and the Clinical Impact of Cytomegalovirus and Epstein-Barr Virus Infections in Pediatric Recipients of TCR-α/β- and CD19-Depleted Grafts.
Laberko A; Bogoyavlenskaya A; Shelikhova L; Shekhovtsova Z; Balashov D; Voronin K; Kurnikova E; Boyakova E; Raykina E; Brilliantova V; Pirumova V; Novichkova G; Maschan A; Maschan M
Biol Blood Marrow Transplant; 2017 Mar; 23(3):483-490. PubMed ID: 28039080
[TBL] [Abstract][Full Text] [Related]
57. [Lymphoproliferative syndromes associated to the Epstein Barr virus in organ transplants].
Hidalgo M; Lumbreras C; Aguado JM
Med Clin (Barc); 1996 Sep; 107(8):310-6. PubMed ID: 8965496
[No Abstract] [Full Text] [Related]
58. Risk assessment in haematopoietic stem cell transplantation: viral status.
Ljungman P
Best Pract Res Clin Haematol; 2007 Jun; 20(2):209-17. PubMed ID: 17448957
[TBL] [Abstract][Full Text] [Related]
59. [Emerging viral pathology in childhood].
Clin Ter; 1992 Feb; 140(2):99-221. PubMed ID: 1568364
[No Abstract] [Full Text] [Related]
60. DNA viruses (CMV, EBV, and the herpesviruses).
Zamora MR
Semin Respir Crit Care Med; 2011 Aug; 32(4):454-70. PubMed ID: 21858750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
